共 15 条
- [1] Clinical and Laboratory Standards Institute, 2005, M100S15 CLSI
- [6] High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of blaACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (10) : 3396 - 3406
- [7] Collateral damage of flomoxef therapy:: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 β-lactamases [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (02) : 410 - 413